Ivabradine
Ivabradine is an approved active ingredient.
Medication used for the symptomatic management of stable heart related chest pain and heart failure not fully managed by beta blockers
What it is used for
- Congestive heart failure
- Cardiomyopathy
- Heart failure
- Cardiovascular disease
- Angina pectoris
1. INDICATIONS AND USAGE Corlanor (ivabradine) is a hyperpolarization-activated cyclic nucleotide-gated channel blocker indicated: To reduce the risk of hospitalization for worsening heart failure in adult patients with stable, symptomatic chronic heart failure with reduced left ventricular…
Symptomatic treatment of chronic stable angina pectoris Ivabradine is indicated for the symptomatic treatment of chronic stable angina pectoris in coronary artery disease adults with normal sinus rhythm and heart rate ? 70 bpm.
How it works
- Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4 blocker
Common side effects
6. ADVERSE REACTIONS Clinically significant adverse reactions that appear in other sections of the labeling include: Atrial Fibrillation Bradycardia and Conduction Disturbances Most common adverse reactions occurring in ≥ 1% of patients are bradycardia, hypertension, atrial fibrillation and luminous phenomena…
Who should not take it
4. CONTRAINDICATIONS Corlanor is contraindicated in patients with: • Acute decompensated heart failure • Clinically significant hypotension • Sick sinus syndrome, sinoatrial block or 3 rd degree AV block, unless a functioning demand pacemaker is present •…
Pregnancy and breastfeeding
Based on findings in animals, Corlanor may cause fetal harm when administered to a pregnant woman. There are no adequate and well-controlled studies of Corlanor in pregnant women to inform any drug-associated risks.
Interactions
- Amiodarone — long QT syndrome, torsades de pointes, sinus bradycardia
- Arsenic trioxide — long QT syndrome, torsades de pointes
- Chlorpromazine — torsades de pointes, long QT syndrome
- Citalopram — long QT syndrome, torsades de pointes
- Clarithromycin — long QT syndrome, torsades de pointes
- Crizotinib — torsades de pointes, long QT syndrome, sinus bradycardia
- Diltiazem — sinus bradycardia
- Donepezil — torsades de pointes, sinus bradycardia, long QT syndrome
- Erythromycin — torsades de pointes, long QT syndrome
- Fingolimod — sinus bradycardia, long QT syndrome
- Galantamine — sinus bradycardia, long QT syndrome
- Haloperidol — torsades de pointes, long QT syndrome
- Hydroxyzine — torsades de pointes, long QT syndrome
- Methadone — long QT syndrome, sinus bradycardia, torsades de pointes
- Moxifloxacin — long QT syndrome, torsades de pointes
- Posaconazole — long QT syndrome
- Ritonavir — long QT syndrome
- Sotalol — torsades de pointes, sinus bradycardia
- Verapamil — sinus bradycardia
- Voriconazole — long QT syndrome, torsades de pointes
- Digoxin
- Nelfinavir
- Phenytoin
- Rifampicin
Brand names
United States
Corlanor
European Union
Ivabradine Accord · Ivabradine Anpharm · Ivabradine Zentiva · Procoralan
Canada
Lancora
Other trade names
Ivabradine jensonr
Approval status
- US Food and Drug Administration
- prescription · since 2015
- European Medicines Agency
- authorised · since 2005
- Health Canada
- prescription · marketed
- First approval anywhere
- 2005
Codes
- ATC
- C01EB17
- RxNorm CUI
- 1649480
- ChEMBL
- CHEMBL471737
- PubChem CID
- 132999
- UNII
- 3H48L0LPZQ
- Wikidata
- Q425729
Frequently asked questions
What is Ivabradine used for?
Ivabradine is used for: Congestive heart failure, Cardiomyopathy, Heart failure, Cardiovascular disease, and Angina pectoris.
What are the brand names of Ivabradine?
Brand names of Ivabradine include Corlanor, Ivabradine Accord, Ivabradine Anpharm, Ivabradine Zentiva, Procoralan, Lancora, and Ivabradine jensonr.
Medicines in the same class
Sources and licences
- ChEMBL (CC BY-SA 3.0)
- Wikidata (CC0 1.0)
- openFDA / DailyMed (public domain)
- European Medicines Agency (reuse with acknowledgement)
- Health Canada Drug Product Database (Open Government Licence – Canada)